Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fabrizio Cantini, Maurizio Benucci, Francesca Li Gobbi, Giulia Franchi & Laura Niccoli. (2019) Biosimilars for the treatment of psoriatic arthritis. Expert Review of Clinical Immunology 15:11, pages 1195-1203.
Read now
Read now
Maurizio Benucci & Fabrizio Cantini. (2019) Non-medical switching: save today and pay tomorrow. Journal of Medical Economics 22:11, pages 1160-1161.
Read now
Read now
Eleftherios Pelechas & Alexandros A. Drosos. (2019) Etanercept biosimilar SB-4. Expert Opinion on Biological Therapy 19:3, pages 173-179.
Read now
Read now
Articles from other publishers (6)
Hugo Jourdain, Léa Hoisnard, Emilie Sbidian & Mahmoud Zureik. (2022) TNF-alpha inhibitors biosimilar use in France: a nationwide population-based study using the French National Health Data System. Scientific Reports 12:1.
Crossref
Crossref
Maurizio Benucci, Arianna Damiani, Francesca Bandinelli, Edda Russo, Francesca Li Gobbi, Valentina Grossi, Amedeo Amedei, Maria Infantino & Mariangela Manfredi. (2022) Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease. Journal of Personalized Medicine 12:7, pages 1174.
Crossref
Crossref
Krzysztof Bonek, Leszek Roszkowski, Magdalena Massalska, Wlodzimierz Maslinski & Marzena Ciechomska. (2021) Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment. Cells 10:2, pages 323.
Crossref
Crossref
Irina A Tikhonova, Huiqin Yang, Segun Bello, Andrew Salmon, Sophie Robinson, Mohsen Rezaei Hemami, Sophie Dodman, Andriy Kharechko, Richard C Haigh, Meghna Jani, Timothy J McDonald & Martin Hoyle. (2021) Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation. Health Technology Assessment 25:8, pages 1-248.
Crossref
Crossref
Yujeong Kim, Hye-Young Kwon, Brian Godman, Evelien Moorkens, Steven Simoens & SeungJin Bae. (2020) Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?. Frontiers in Pharmacology 11.
Crossref
Crossref
Daniel C. Baumgart, Laurent Misery, Sue Naeyaert & Peter C. Taylor. (2019) Biological Therapies in Immune-Mediated Inflammatory Diseases: Can Biosimilars Reduce Access Inequities?. Frontiers in Pharmacology 10.
Crossref
Crossref